Tipirneni Praveen P. 4

What Happened
Director Praveen P. Tipirneni was granted a derivative award for 10,200 shares of Tectonic Therapeutic (TECX) on June 9, 2026. The reported acquisition price is $0.00, so no cash was paid; the instrument is reported as a derivative award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-09; Filing date: 2026-06-10 (Form 4) — timely filing.
• Instrument: Reported as a grant/award (derivative) of 10,200 shares at $0.00; total cash value reported = $0.
• Shares owned after transaction: Not disclosed in the provided filing data.
• Footnote: The award vests in full on the earliest of (i) June 9, 2027, (ii) the issuer’s 2027 Annual Meeting, or (iii) a “Change in Control,” provided the reporting person remains in continuous service.
• No indication of 10b5-1 plan, tax withholding, or late filing in this report.

Context
This is a compensation/retention-type equity award (derivative) and not an open-market buy or sale, so it does not directly signal insider buying or selling sentiment. The vesting schedule means the shares aren’t immediately unencumbered—value to the insider depends on continued service or a triggering event (annual meeting date or change in control).